CT83 and gastric adenocarcinoma: Conversely, the abnormal activation of CT83 is often detected in cancer tissues including breast cancer, and its high expression is statistically different from paired normal tissues in lung adenocarcinoma (LUAD) and stomach adenocarcinoma (STAD) tissues.